Treatment of peritoneal carcinomatosis in gastric cancers

Digestive Diseases

Volumn 22, Issue 4, 2004, Pages 366-373

  Brigand, C ^a   Arvieux, C ^b,c   Gilly, F N ^b,d   Glehen, O ^b,d  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b UNIVERSITÉ CLAUDE BERNARD LYON 1   (France)

^c HÔPITAL MICHALLON   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Gastric cancer; Hyperthermia; Intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; METHOTREXATE; MITOMYCIN C; OXALIPLATIN; PACLITAXEL;

ABDOMINAL ABSCESS; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CHOLECYSTECTOMY; CLINICAL TRIAL; COLORECTAL CANCER; COMPARATIVE STUDY; CYTOREDUCTIVE SURGERY; CYTOTOXICITY; DISEASE COURSE; DRUG TRANSPORT; GASTROINTESTINAL CARCINOMA; HUMAN; LYMPHADENECTOMY; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; QUALITY OF LIFE; REVIEW; SIDE EFFECT; STOMACH CANCER; TEMPERATURE; TOTAL STOMACH RESECTION; TOXICITY; TREATMENT OUTCOME; VISCERAL METASTASIS; CARCINOMA; GASTRECTOMY; IATROGENIC DISEASE; METASTASIS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEUM TUMOR; STOMACH TUMOR;

CARCINOMA; COMBINED MODALITY THERAPY; GASTRECTOMY; HUMANS; NEOPLASM SEEDING; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS;

EID: 21844443897     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083600     Document Type: Review

References (57)

1. Roviello F, Marrelli D, De Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A: Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003;90:1113-1119.
2. Japanese Gastric Cancer A: Japanese Classification of Gastric Carcinoma, 2nd Engl ed. Gastric Cancer 1998;1:10-24.
3. Lauren PA, Nevalainen TJ: Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer 1993;71:2926-2933.
4. Maehara Y, Emi Y, Baba H, Adachi Y, Akazawa K, Ichiyoshi Y, Sugimachi K: Recurrences and related characteristics of gastric cancer. Br J Cancer 1996;74:975-979.
5. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS: Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-242.
6. Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, Fushida S, Fujimura T, Nishimura G, Miwa K: Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999;178:256-262.
7. Ikeguchi M, Oka A, Tsujitani S, Maeta M, Kaibara N: Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer. Anticancer Res 1994;14:2131-2134.
8. Iitsuka Y, Kaneshima S, Tanida O, Takeuchi T, Koga S: Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 1979;44:1476-1480.
9. Sugarbaker PH: Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Cancer Treat Res 1996;82:79-100.
10. Sugarbaker PH, Yu W, Yonemura Y: Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: The evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 2003;21:233-248.
11. Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, Francois Y, Vignal J, Gilly FN: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358-363.
12. Hu JK, Chen ZX, Zhou ZG, Zhang B, Tian J, Chen JP, Wang L, Wang CH, Chen HY, Li YP: Intravenous chemotherapy for resected gastric cancer: Meta-analysis of randomized controlled trials. World J Gastroenterol 2002;8:1023-1028.
13. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M, Van de Velde CJ: Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 1993;11:1441-1447.
14. Janunger KG, Hafstrom L, Glimelius B: Chemotherapy in gastric cancer: A review and updated meta-analysis. Eur J Surg 2002;168:597-608.
15. Souglakos J, Syrigos K, Potamianou A, Polyzos A, Boukovinas I, Androulakis N, Kouroussis C, Vardakis N, Christophilakis C, Kotsakis A, Georgoulias V: Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: A multicentre phase II trial. Ann Oncol 2004;15:1204-1209.
16. Yoshida M, Boku N, Ohtsu A, Muto M, Nagashima F, Yoshida S: Combination chemotherapy of irinotecan plus cisplatin for advanced gastric cancer: Efficacy and feasibility in clinical practice. Gastric Cancer 2001;4:144-149.
17. Newman E, Marcus SG, Potmesil M, Sewak S, Yee H, Sorich J, Hayek M, Muggia F, Hochster H: Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer. J Gastrointest Surg 2002;6:212-223.
18. Schuhmacher CP, Fink U, Becker K, Busch R, Dittler HJ, Mueller J, Siewert JR: Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up. Cancer 2001;91:918-927.
19. Ott K, Sendler A, Becker K, Dittler HJ, Helmberger H, Busch R, Kollmannsberger C, Siewert JR, Fink U: Neoadjuvant chemotherapy with cisplatin. 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: A prospective phase II study. Gastric Cancer 2003;6:159-167.
20. Marcus SG, Cohen D, Lin K, Wong K, Thompson S, Rothberger A, Potmesil M, Hiotis S, Newman E: Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer. J Gastrointest Surg 2003;7:1015-1023.
21. Hartgrink HH, van de Velde CJ, Putter H, Songun I, Tesselaar ME, Kranenbarg EK, de Vries JE, Wils JA, van der Bijl J, van Krieken JH: Neo-adjuvant chemotherapy for operable gastric cancer: Long-term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol 2004; 30:643-649.
22. Hallissey MT, Allum WH, Roginski C, Fielding JW: Palliative surgery for gastric cancer. Cancer 1988;62:440-444.
23. Haugstvedt T, Viste A, Eide GE, Soreide O: The survival benefit of resection in patients with advanced stomach cancer: The Norwegian multicenter experience. Norwegian Stomach Cancer Trial. World J Surg 1989;13:617-622.
24. Isozaki H, Okajima K, Kawashima Y, Yamada S, Nakata E, Nishimura J, Ichinona T: Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery. J Surg Oncol 1993;53:247-251.
25. Maekawa S, Saku M, Maehara Y, Sadanaga N, Ikejiri K, Anai H, Kuwano H, Sugimachi K: Surgical treatment for advanced gastric cancer. Hepatogastroenterology 1996;43:178-186.
26. Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ: Value of palliative resection in gastric cancer. Br J Surg 2002;89:1438-1443.
27. Hagiwara A, Sawai K, Sakakura C, Shirasu M, Ohgaki M, Yamasaki J, Togawa T, Takahashi T: Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum. Hepatogastroenterology 1998;45:1922-1929.
28. Yonemura Y, Fujimura T, Fushida S, Fujita H, Bando E, Nishimura G, Miwa K, Endou Y, Tanaka M, Sasaki T: A new surgical approach (peritonectomy) for the treatment of peritoneal dissemination. Hepatogastroenterology 1999;46:601-609.
29. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-748.
30. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M: Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 2004;22:2069-2077.
31. Sugarbaker PH: Peritonectomy procedures. Ann Surg 1995;221:29-42.
32. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Arimizu N, et al: Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36-41.
33. Fujimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T, Sugiyama K, Hasegawa H, Katayama K, Miwa K: Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65-71.
34. Armour EP, McEachern D, Wang Z, Corry PM, Martinez A: Sensitivity of human cells to mild hyperthermia. Cancer Res 1993;53:2740-2744.
35. Reed RA, Bedford JS: Thermal tolerance. Br J Radiol 1980;53:920-921.
36. Hahn GM: Potential for therapy of drugs and hyperthermia. Cancer Res 1979;39:2264-2268.
37. Bull JM: An update on the anticancer effects of a combination of chemotherapy and hyperthermia. Cancer Res 1984;44(suppl):4853-4856.
38. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC: Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41:1096-1099.
39. Jacquet P, Averbach A, Stephens AD, Stuart OA, Chang D, Sugarbaker PH: Heated intraoperative intraperitoneal mitomycin C, early postoperative intraperitoneal 5-fluorouracil: Pharmacokinetic studies. Oncology 1998;55:130-138.
40. Ceelen WP, Hesse U, de Hemptinne B, Pattyn P: Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000;87:1006-1015.
41. Averbach AM, Sugarbaker PH: Methodologic considerations in treatment using intraperitoneal chemotherapy. Cancer Treat Res 1996;82:289-309.
42. Hall JJ, Loggie BW, Shen P, Beamer S, Douglas Case L, McQuellon R, Geisinger KR, Levine EA: Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004;8:454-463.
43. Elias D, Blot F, El Otmany A, Antoun S, Lasser P, Boige V, Rougier P, Ducreux M: Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71-76.
44. Barakat RR, Sabbatini P, Bhaskaran D, Revzin M, Smith A, Venkatraman E, Aghajanian C, Hensley M, Soignet S, Brown C, Soslow R, Markman M, Hoskins WJ, Spriggs D: Intraperitoneal chemotherapy for ovarian carcinoma: Results of long-term follow-up. J Clin Oncol 2002;20:694-698.
45. Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinski D, Freyer G, Francois Y, Vignal J, Gilly FN: Treatment of peritoneal carcinomatosis arising from gastric cancer by cytoreductive surgery and intraperitoneal chemohyperthermia. Arch Surg 2004;139:20-26.
46. Stephens AD, Alderman R, Chang D, Edwards GD, Esquivel J, Sebbag G, Steves MA, Sugarbaker PH: Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6:790-796.
47. Yonemura Y, Fujimura T, Nishimura G, Falla R, Sawa T, Katayama K, Tsugawa K, Fushida S, Miyazaki I, Tanaka M, Endou Y, Sasaki T: Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996;119:437-444.
48. Sayag-Beaujard AC, Francois Y, Glehen O, Sadeghi-Looyeh B, Bienvenu J, Panteix G, Garbit F, Grandclement E, Vignal J, Gilly FN: Intraperitoneal chemohyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res 1999;19:1375-1382.
49. Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T, Isawa E, Sumida M, Ohkubo H: Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997;79:884-891.
50. Hirose K, Katayama K, Iida A, Yamaguchi A, Nakagawara G, Umeda S, Kusaka Y: Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: Evaluation by multivariate regression analysis. Oncology 1999;57:106-114.
51. Glehen O, Mithieux F, Osinski D, Beaujard AC, Freyer G, Guerscht P, et al: Digestive surgery combined with peritonectomy procedures and intraperitoneal chemo-hyperthermia in abdominal cancers with peritoneal carcinomatosis: A phase II study. J Clin Oncol 2003;21:789-806.
52. Shen P, Levine EA, Hall J, Case D, Russell G, Fleming R, McQuellon R, Geisinger KR, Loggie BW: Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003;138:26-33.
53. 3 Kim JY, Bae HS: A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion. Gastric Cancer 2001;4:27-33.
54. Hamazoe R, Maeta M, Kaibara N: Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994;73:2048-2052.
55. Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, Sugiyama K, Kawamura T, Kinoshita K, Endou Y, Sasaki T: Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: Final results of a randomized controlled study. Hepatogastroenterology 2001;48:1776-1782.
56. Kunisaki C, Shimada H, Nomura M, Akiyama H, Takahashi M, Matsuda G: Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery 2002;131:521-528.
57. Samel S, Singal A, Becker H, Post S: Problems with intraoperative hyperthermic peritoneal chemotherapy for advanced gastric cancer. Eur J Surg Oncol 2000;26:222-226.